NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Acute Suicidal Ideation and Behavior: The SBD-ASIB Study
Phase of Trial: Phase II/III
Latest Information Update: 21 Dec 2018
At a glance
- Drugs Cycloserine/lurasidone (Primary) ; Ketamine; Lurasidone
- Indications Bipolar depression; Suicidal ideation
- Focus Registrational; Therapeutic Use
- Acronyms SBD-ASIB
- Sponsors NeuroRX
- 29 Nov 2018 Planned End Date changed from 31 Mar 2019 to 31 Mar 2020.
- 29 Nov 2018 Planned primary completion date changed from 31 Mar 2019 to 31 Dec 2019.
- 29 Nov 2018 Planned initiation date changed from 1 May 2018 to 1 Jan 2019.